ProQR Therapeutics (PRQR) Short Interest Ratio & Short Volume → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free PRQR Stock Alerts $1.99 -0.02 (-1.00%) (As of 01:29 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ProQR Therapeutics Short Interest DataCurrent Short Volume241,500 sharesPrevious Short Volume261,100 sharesChange Vs. Previous Month-7.51%Dollar Volume Sold Short$493,867.50Short Interest Ratio / Days to Cover1.2Last Record DateApril 15, 2024Outstanding Shares81,360,000 sharesFloat Size51,890,000 sharesShort Percent of Float0.47%Today's Trading Volume103,395 sharesAverage Trading Volume275,275 sharesToday's Volume Vs. Average38% Short Selling ProQR Therapeutics ? Sign up to receive the latest short interest report for ProQR Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRQR Short Interest Over TimePRQR Days to Cover Over TimePRQR Percentage of Float Shorted Over Time Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. ProQR Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024241,500 shares $493,867.50 -7.5%0.5%1.2 $2.05 3/31/2024261,100 shares $597,892.89 -4.0%0.5%0.9 $2.29 3/15/2024272,100 shares $696,576.00 +3.1%0.5%0.9 $2.56 2/29/2024263,900 shares $533,078.00 -17.3%0.6%0.9 $2.02 2/15/2024319,000 shares $622,050.00 +5.9%0.7%1 $1.95 1/31/2024301,300 shares $653,821.00 -39.1%0.6%0.9 $2.17 Get the Latest News and Ratings for PRQR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024494,800 shares $1.10 million -27.3%1.0%1.6 $2.23 12/31/2023680,400 shares $1.35 million -30.7%1.4%3.3 $1.98 12/15/2023981,100 shares $2.11 million +55.8%2.0%4.3 $2.15 11/30/2023629,800 shares $976,190.00 +2.6%1.3%2.9 $1.55 11/15/2023613,600 shares $908,128.00 -9.0%1.2%3.5 $1.48 10/31/2023674,200 shares $775,330.00 -4.5%1.4%3.8 $1.15 10/15/2023705,800 shares $868,134.00 +2.9%1.4%3.7 $1.23 9/30/2023685,900 shares $891,670.00 -24.4%1.4%3.3 $1.30 9/15/2023907,500 shares $1.46 million -3.6%1.8%4.7 $1.61 8/31/2023940,900 shares $1.51 million -2.9%1.7%3.9 $1.61 8/15/2023969,400 shares $1.49 million -16.4%1.8%3.5 $1.54 7/31/20231,160,000 shares $1.74 million +148.1%2.1%3.6 $1.50 7/15/2023467,600 shares $818,300.00 -2.9%0.9%1.3 $1.75 6/30/2023481,300 shares $779,706.00 -8.4%0.9%1.2 $1.62 6/15/2023525,200 shares $892,840.00 -34.0%0.9%0.8 $1.70 5/31/2023796,200 shares $1.39 million -41.9%1.4%1 $1.74 5/15/20231,370,000 shares $2.63 million -33.5%2.5%1.6 $1.92 4/30/20232,060,000 shares $4.49 million -20.2%3.7%2.3 $2.18 4/15/20232,580,000 shares $5.75 million -4.1%4.6%2.6 $2.23 3/31/20232,690,000 shares $5.73 million +66.1%5.1%2.2 $2.13 3/15/20231,620,000 shares $5.02 million +21.8%3.5%0.6 $3.10 2/28/20231,330,000 shares $3.92 million +16.7%2.9%0.5 $2.95 2/15/20231,140,000 shares $3.28 million -23.0%2.5%0.4 $2.88 1/31/20231,480,000 shares $4.08 million -20.0%3.1%0.5 $2.76 1/15/20231,850,000 shares $6.35 million -7.5%3.9%0.6 $3.43 12/30/20222,000,000 shares $7.40 million +102.0%4.2%0.8 $3.70 12/15/2022990,200 shares $1.64 million +0.1%1.7%0.4 $1.66 11/30/2022989,600 shares $1.22 million +44.3%1.7%1.3 $1.23 11/15/2022685,700 shares $654,980.64 -34.7%1.2%1 $0.96 10/31/20221,050,000 shares $971,355.00 -16.0%1.8%1.9 $0.93 10/15/20221,250,000 shares $1.11 million +131.4%2.2%2.6 $0.89 9/30/2022540,300 shares $401,983.20 +54.6%0.9%1.2 $0.74 9/15/2022349,600 shares $276,114.08 +1.7%0.6%0.9 $0.79 8/31/2022343,900 shares $271,646.61 +6.7%0.6%0.8 $0.79World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. PRQR Short Interest - Frequently Asked Questions What is ProQR Therapeutics' current short interest? Short interest is the volume of ProQR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 241,500 shares of PRQR short. 0.47% of ProQR Therapeutics' shares are currently sold short. Learn More on ProQR Therapeutics' current short interest. What is a good short interest ratio for ProQR Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRQR shares currently have a short interest ratio of 1.0. Learn More on ProQR Therapeutics's short interest ratio. Which institutional investors are shorting ProQR Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ProQR Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ProQR Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.47% of ProQR Therapeutics' floating shares are currently sold short. Is ProQR Therapeutics' short interest increasing or decreasing? ProQR Therapeutics saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 241,500 shares, a decline of 7.5% from the previous total of 261,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ProQR Therapeutics' float size? ProQR Therapeutics currently has issued a total of 81,360,000 shares. Some of ProQR Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ProQR Therapeutics currently has a public float of 51,890,000 shares. How does ProQR Therapeutics' short interest compare to its competitors? 0.47% of ProQR Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ProQR Therapeutics: scPharmaceuticals Inc. (13.26%), Gossamer Bio, Inc. (4.93%), Greenwich LifeSciences, Inc. (3.17%), Adicet Bio, Inc. (9.55%), Inventiva S.A. (0.15%), Skye Bioscience, Inc. (0.29%), Capricor Therapeutics Inc (11.40%), CervoMed Inc. (0.71%), Omeros Co. (23.62%), Regulus Therapeutics Inc. (10.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ProQR Therapeutics stock? Short selling PRQR is an investing strategy that aims to generate trading profit from ProQR Therapeutics as its price is falling. PRQR shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProQR Therapeutics? A short squeeze for ProQR Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PRQR, which in turn drives the price of the stock up even further. How often is ProQR Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRQR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SCPH Short Interest GOSS Short Interest GLSI Short Interest ACET Short Interest IVA Short Interest SKYE Short Interest CAPR Short Interest CRVO Short Interest OMER Short Interest RGLS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRQR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press